[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:fibrosarcoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":28,"states":29},"Fibrosarcoma",3,[7,15,22],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06239272","NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)",[11],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:18:06.247899Z","2026-07-19T19:36:05.068230Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06881992","A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism",[19],"Phase 3","2026-08-26T02:17:23.750999Z","2026-05-05T02:43:28.217045Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT06387485","A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning",[],"2026-08-26T02:18:34.622081Z","2026-05-05T02:43:28.883449Z",[],[30],{"state":31,"count":5,"slug":32},"Ohio","ohio"]